Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12583943 | Anti-tetrodotoxin antibody C31K8, and preparation method and use thereof | 🖼🧊📄§ | 2026-03-24 | 2042-12-20 | 0 | 31 |
| 12582614 | Composition for preventing, alleviating or treating sarcopenia, containing D-ribo-2-hexulose as active ingredient | 🖼🧊📄§ | 2026-03-24 | 2042-03-04 | 0 | 31 |
| 12584146 | Synthetic modified vaccinia Ankara (SMVA) based coronavirus vaccines | 🖼🧊📄§ | 2026-03-24 | 2045-04-18 | 0 | 31 |
| 12582613 | Biomimetic, reactive oxygen species-detonable nanoclusters for antirestenotic therapy | 🖼🧊📄§ | 2026-03-24 | 2042-07-21 | 0 | 31 |
| 12582652 | 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator | 🖼🧊📄§ | 2026-03-24 | 2044-10-25 | 0 | 31 |
| 12582670 | Lignin solvation using aqueous biologically compatible buffers | 🖼🧊📄§ | 2026-03-24 | 2040-01-10 | 0 | 31 |
| 12582723 | Polynucleotides encoding a human FKRP protein | 🖼🧊📄§ | 2026-03-24 | 2043-03-02 | 0 | 31 |
| 12582672 | Vanadium compositions and methods for treatment of cancer | 🖼🧊📄§ | 2026-03-24 | 2039-11-13 | 0 | 31 |
| 12582685 | Uses of saccharides from prasinococcales | 🖼🧊📄§ | 2026-03-24 | 2041-07-27 | 0 | 31 |
| 12582680 | Pharmaceutical composition for prevention, amelioration, or treatment of skin disease | 🖼🧊📄§ | 2026-03-24 | 2040-02-03 | 0 | 31 |
| 12582676 | Hydrogel particle encapsulated viable cells for in vivo regenerative treatment | 🖼🧊📄§ | 2026-03-24 | 2043-07-18 | 0 | 31 |
| 12582645 | Chemokine CXCR4 receptor modulators and uses related thereto | 🖼🧊📄§ | 2026-03-24 | 2044-05-03 | 0 | 31 |
| 12582678 | Method for treating pleural effusion | 🖼🧊📄§ | 2026-03-24 | 2042-09-30 | 0 | 31 |
| 12582662 | Injectable pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent and a preservative | 🖼🧊📄§ | 2026-03-24 | 2043-05-26 | 0 | 31 |
| 12582725 | AAV vectors with myelin protein zero promoter and uses thereof for treating SCHWANN cell-associated diseases like CHARCOT-MARIE-TOOTH disease | 🖼🧊📄§ | 2026-03-24 | 2040-06-03 | 0 | 31 |
| 12582146 | Angiotensin-converting enzyme inhibitor, blood pressure-lowering agent, and beverages and food products | 🖼🧊📄§ | 2026-03-24 | 2040-09-02 | 0 | 31 |
| 12582696 | Debaryomyces species as an indicator of non-healing ulcers in Crohn's disease | 🖼🧊📄§ | 2026-03-24 | 2040-12-10 | 0 | 31 |
| 12582697 | Antisecretory factor for use in treatment and/or prevention of acute respiratory failure | 🖼🧊📄§ | 2026-03-24 | 2039-06-26 | 0 | 31 |
| 12582690 | Compositions for preventing or treating cancer comprising extracts of Rubus longisepalus var. tozawai (nakai) t.b.lee | 🖼🧊📄§ | 2026-03-24 | 2042-10-07 | 0 | 31 |
| 12582691 | Administration of Yunnan Baiyao or Xingnaojing in patients with moderate-to-severe traumatic brain injury and craniotomy | 🖼🧊📄§ | 2026-03-24 | 2042-07-12 | 0 | 31 |
| 12583844 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-11-13 | 0 | 31 |
| 12584919 | Enhancing anti-tumor response in melanoma cells with defective sting signaling | 🖼🧊📄§ | 2026-03-24 | 2042-09-16 | 0 | 31 |
| 12583832 | Cannabinoid analogs, formulations, and methods of use | 🖼🧊📄§ | 2026-03-24 | 2045-09-04 | 0 | 31 |
| 12583860 | Processes for the preparation of multicomponent crystalline forms of active pharmaceutical ingredients using solvent vapour | 🖼🧊📄§ | 2026-03-24 | 2041-02-24 | 0 | 31 |
| 12582500 | Methods and systems to automate surgical interventions | 🖼🧊📄§ | 2026-03-24 | 2043-07-28 | 0 | 31 |
| 12583894 | Materials and methods for the treatment of Lewy body disorders | 🖼🧊📄§ | 2026-03-24 | 2039-04-03 | 0 | 31 |
| 12582649 | Compositions and methods for hair follicle regeneration | 🖼🧊📄§ | 2026-03-24 | 2041-06-03 | 0 | 31 |
| 12582106 | IL-15 humanized mouse model and use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-12-24 | 0 | 31 |
| 12583893 | Use of esculentin and its derivatives for use in the treatment of cystic fibrosis | 🖼🧊📄§ | 2026-03-24 | 2040-10-09 | 0 | 31 |
| 12582635 | Compositions and methods for treating cancer with atypical BRAF mutations | 🖼🧊📄§ | 2026-03-24 | 2038-05-15 | 0 | 31 |
| 12583858 | TDO2 inhibitors | 🖼🧊📄§ | 2026-03-24 | 2040-10-12 | 0 | 31 |
| 12583834 | Method of treating bacterial infections and pharmaceutical composition for treating bacterial infections | 🖼🧊📄§ | 2026-03-24 | 2041-02-19 | 0 | 31 |
| 12583841 | Tetrahydropyrrolocyclic compound and application thereof | 🖼🧊📄§ | 2026-03-24 | 2042-01-27 | 0 | 31 |
| 12582617 | Methods for treating cancer | 🖼🧊📄§ | 2026-03-24 | 2042-06-29 | 0 | 31 |
| 12582638 | Pharmaceutical composition for treating cancer, containing mTOR-signaling inhibitor as active ingredient | 🖼🧊📄§ | 2026-03-24 | 2041-02-19 | 0 | 31 |
| 12583936 | Subcutaneous formulations of anti-CD38 antibodies and their uses | 🖼🧊📄§ | 2026-03-24 | 2045-05-05 | 0 | 31 |
| 12582639 | Preventive, relief or therapeutic use of 2,3,5-substituted thiophene compound against gastrointestinal stromal tumor | 🖼🧊📄§ | 2026-03-24 | 2041-07-30 | 0 | 31 |
| 12582631 | Methods of improving renal function | 🖼🧊📄§ | 2026-03-24 | 2042-08-16 | 0 | 31 |
| 12582648 | Method for treating central nervous system disorders using dopamine D3 partial agonists | 🖼🧊📄§ | 2026-03-24 | 2041-05-04 | 0 | 31 |
| 12582632 | Inhibition of neurological injuries due to infections via administration of Butanetap and analogs thereof | 🖼🧊📄§ | 2026-03-24 | 2042-05-17 | 0 | 31 |
| 12583925 | Bispecific antibodies targeting PD1 and VEGF | 🖼🧊📄§ | 2026-03-24 | 2044-09-26 | 0 | 31 |
| 12583926 | CD47/pd-L1-targeting protein complex and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2044-07-12 | 0 | 31 |
| 12583940 | Monoclonal antibody which targets TFPI | 🖼🧊📄§ | 2026-03-24 | 2040-08-28 | 0 | 31 |
| 12582661 | Synthesis and application of class of respiratory syncytial virus inhibitors | 🖼🧊📄§ | 2026-03-24 | 2041-01-21 | 0 | 31 |
| 12583891 | Peptides and methods for the treatment of diabetes | 🖼🧊📄§ | 2026-03-24 | 2043-08-08 | 0 | 31 |
| 12583889 | Cell penetrating peptides | 🖼🧊📄§ | 2026-03-24 | 2041-04-23 | 0 | 31 |
| 12583816 | Lipids for lipid nanoparticle delivery of active agents | 🖼🧊📄§ | 2026-03-24 | 2039-10-18 | 0 | 31 |
| 12583887 | PSMA imaging agents | 🖼🧊📄§ | 2026-03-24 | 2040-08-21 | 0 | 31 |
| 12583808 | Biobased alkyl glyceryl ethers and methods of making and using the same | 🖼🧊📄§ | 2026-03-24 | 2041-05-24 | 0 | 31 |
| 12583918 | Therapeutic agent for urological cancer which is characterized by being administered with IL-6 inhibitor and CCR2 inhibitor in combination | 🖼🧊📄§ | 2026-03-24 | 2040-04-16 | 0 | 31 |